Search bioRxiv⌕ Search

Biology subjects

Eberl, H. C.

Publications and source records attributed to Eberl, H. C..

3 recordsLinked to original sources

Pharmacoproteomic profiling identifies secreted markers for aberrant drug action

Adverse drug reactions (ADRs) contribute significantly to late-stage attrition in drug discovery due to their unpredictability and enigmatic underlying mechanisms. Here we applied mass spectrometry-based proteomics to assess the effects of 46 approved or retracted drugs with various levels of concerns for drug-induced liver injury and annotated for mitochondrial mechanisms, along with 8 tool compounds, on the secretome of a hepatocyte liver model. We observed distinct clusters of non-canonical secretion, and intracellular thermal proteome profiling linked dysregulated mechanisms to extracellular markers. Functional follow-up confirmed lysosomal alterations by cationic-amphiphilic drugs, connected damage of the respiratory chain to Rab7-dependent secretion of mitochondrial proteins, and linked drug-induced endoplasmic reticulum stress to reduced basal secretion. Perturbation of sphingolipid biosynthesis pathways specifically induced secretion of the cargo sorting protein SDF4 whilst suppressing secretion of its cargo proteins. Thermal stability changes of clusters of membrane proteins in distinct subcellular compartments suggest local accumulation as important driver for unexpected drug effects through direct and indirect interactions.

pharmacology and toxicology↗

Integration of Thermal Proteome Profiling with phosphoproteomic and transcriptomic data via mechanistic network models decodes the molecular response to PARP inhibition

The deregulation of complex diseases often spans multiple molecular processes. A multimodal functional characterization of these processes can shed light on the disease mechanisms and the effect of drugs. Thermal Proteome Profiling (TPP) is a mass-spectrometry based technique assessing changes in thermal protein stability that can serve as proxies of functional changes of the proteome. These unique insights of TPP can complement those obtained by other omics technologies. Here, we show how TPP can be integrated with phosphoproteomics and transcriptomics in a network-based approach using COSMOS, a framework for causal integration of multi-omics, to provide an integrated view of transcription factors, kinases and proteins with altered thermal stability. This allowed us to recover known mechanistic consequences of PARP inhibition in ovarian cancer cells on cell cycle and DNA damage response in detail and to uncover new insights into drug response mechanisms related to interferon and hippo signaling. We found that TPP complements the other omics data and allowed us to obtain a network model with higher coverage of the main underlying mechanisms. These results illustrate the added value of TPP, and more generally the power of network models to integrate the information provided by different omics technologies. We anticipate that this strategy can be used to broadly integrate functional proteomics with other omics to study complex molecular processes. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=63 SRC="FIGDIR/small/553354v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@af952eorg.highwire.dtl.DTLVardef@16b1d1borg.highwire.dtl.DTLVardef@1440787org.highwire.dtl.DTLVardef@14a4227_HPS_FORMAT_FIGEXP M_FIG C_FIG

systems biology↗

Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivo

Studying biological processes at a molecular level and monitoring drug-target interactions is established for simple cell systems but challenging in vivo. We introduce and apply a methodology for proteome-wide thermal stability measurements to characterize organ physiology and activity of many fundamental biological processes across tissues, such as energy metabolism and protein homeostasis. This method, termed tissue thermal proteome profiling (tissue-TPP), also enabled target and off-target identification and occupancy measurements in tissues derived from animals dosed with the non-covalent histone deacetylase inhibitor, panobinostat. Finally, we devised blood-CETSA, a thermal stability-based method to monitor target engagement in whole blood. Our study generates the first proteome-wide map of protein thermal stability in tissue and provides tools that will be of great impact for translational research.

cell biology↗